Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Achyut Healthcare's board met on January 21, 2026 and approved several key items. The company posted Q3 FY26 revenue of Rs. 156.96 lakhs and a 9-month revenue of Rs. 720.83 lakhs (up from Rs. 212.66 lakhs a year ago), but Q3 net profit slipped to just Rs. 0.43 lakhs and 9-month net profit fell to Rs. 23.73 lakhs from Rs. 38.59 lakhs. The board also cleared a preferential issue of up to 58 lakh equity shares at Rs. 6 each (Rs. 5 premium) to raise Rs. 3.48 crore, with 12 lakh shares going to promoter group entities and 46 lakh shares to non-promoter allottees. Additionally, the board approved increasing authorized capital from Rs. 24 crore to Rs. 26 crore, shifting the registered office within Ahmedabad, and called an EGM for February 19, 2026. The company recently migrated from BSE SME to BSE Mainboard effective January 2, 2026, and has adopted Ind AS from April 1, 2025.
The Q3 results are weak with a sharp drop in both revenue and profit, which may weigh on the stock. However, the Rs. 3.48 crore preferential issue at a healthy premium and the migration to the BSE Mainboard could improve liquidity and visibility, though the dilution from the new shares is a near-term concern for existing shareholders.